Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

IVERIC bio, Inc. - Common Stock (NQ:ISEE)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IVERIC bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Iveric Bio Reports Third Quarter 2022 Operational Highlights and Financial Results
From IVERIC bio, Inc.
Via Business Wire
IVERIC bio's Earnings: A Preview
IVERIC bio (NASDAQ:ISEE) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that IVERIC bio will... 
Via Benzinga
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio to Report Third Quarter 2022 Financial Results and Host Conference Call on Thursday, November 3, 2022
From IVERIC bio, Inc.
Via Business Wire
Watch for Continued Gains in Shares of IVERIC bio Inc. (ISEE)
Via Investor Brand Network
Analyst Ratings for IVERIC bio
Within the last quarter, IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings: 
Via Benzinga
RPM International, Lamb Weston And Some Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Iveric Bio to Present Top-line Results for Avacincaptad Pegol from Phase 3 GATHER2 Clinical Trial in Geographic Atrophy at AAO 2022 Annual Meeting
From IVERIC bio, Inc.
Via Business Wire
Where IVERIC bio Stands With Analysts
IVERIC bio (NASDAQ:ISEE) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Nikola, Bed Bath & Beyond And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning ahead of the PPI data for August. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to... 
Via Benzinga
AeroVironment, Snap And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Starbucks To $94? Here Are 5 Other Price Target Changes For Wednesday
Citigroup raised the price target on Starbucks Corporation (NASDAQ: SBUX) from $90 to $94. Citigroup analyst Jon Tower maintained a Neutral rating on the stock. Starbucks shares fell 0.1% to $84.50 in... 
Via Benzinga
Iveric Bio to Present at Upcoming Investor Conferences
From IVERIC bio, Inc.
Via Business Wire
ADT, Manchester United And Other Big Gainers From Tuesday
U.S. stocks closed lower with the Dow Jones dropping around 173 points on Tuesday. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility. 
Via Benzinga
Iveric Bio (NASDAQ: ISEE) Reports Positive Topline Phase 3 Trial Data for Zimura, Plans to Submit FDA New Drug Application Q1 2023
Iveric Bio, Inc. (NASDAQ: ISEE) is engaged as a biopharmaceutical company, which is focused on the research and development of 
Via Spotlight Growth
Exposures Product Safety
Dow Tumbles Over 200 Points; ChannelAdvisor Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 200 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
  
Via Benzinga
Nasdaq Drops 100 Points; DWAC Shares Plummet
U.S. stocks traded lower midway through trading, with the Nasdaq dropping over 100 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow dropping around... 
Via Benzinga
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session
Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist... 
Via Benzinga
Most Active Equity Options For Midday - Tuesday, Sept. 6
Here are the most active equity options for midday. 
Via Talk Markets
Stocks Staying Afloat Amid Holiday Doldrums
The Dow Jones Industrial Average is 54 points higher midday, paring steep morning losses as traders unpack stronger-than-anticipated PMI data. 
Via Talk Markets
FAZE, PETS: The Top 5 Short Squeeze Stocks to Watch This Week
We're covering the top short squeeze stocks of the week that traders are going to want to keep an eye on with those most likely to squeeze. 
Via InvestorPlace
$100 Invested In IVERIC bio 5 Years Ago Would Be Worth This Much Today
IVERIC bio (NASDAQ:ISEE) has outperformed the market over the past 5 years by 31.63% on an annualized basis producing an average annual return of 41.11%. Currently, IVERIC bio has a market... 
Via Benzinga
Why Is Iveric Bio (ISEE) Stock Up 56% Today?
Iveric Bio (ISEE) stock is rising higher Tuesday after the biopharmaceutical company revealed positive results from a Phase 3 clinical trial. 
Via InvestorPlace
US Stocks Trade Lower; Dow Drops Over 100 points
U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow dropping around 3%,... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.